In a malignant melanoma, ILC2-derived granulocyte macrophage–colony stimulating factor (GM-CSF) induced tumor-infiltrating eosinophils and exerted antitumor effects, which were exacerbated by antibody-mediated inhibition of PD-1 on ILC2s [25]. The gene discussed is CSF2; the disease is neoplasm.